vs
Side-by-side financial comparison of Strive, Inc. (ASST) and Vir Biotechnology, Inc. (VIR). Click either name above to swap in a different company.
Strive, Inc. is the larger business by last-quarter revenue ($255.0K vs $240.0K, roughly 1.1× Vir Biotechnology, Inc.). Vir Biotechnology, Inc. runs the higher net margin — -67975.4% vs -75406.7%, a 7431.3% gap on every dollar of revenue. On growth, Strive, Inc. posted the faster year-over-year revenue change (-74.1% vs -89.9%). Over the past eight quarters, Strive, Inc.'s revenue compounded faster (77.6% CAGR vs -88.0%).
Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on developing innovative therapies and vaccines to address serious infectious diseases including COVID-19, hepatitis B, HIV, and influenza. It operates primarily in the global biopharmaceutical market, collaborating with leading industry partners to advance its pipeline of targeted immune-based solutions for patient populations worldwide.
ASST vs VIR — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $255.0K | $240.0K |
| Net Profit | $-192.3M | $-163.1M |
| Gross Margin | — | — |
| Operating Margin | -17288.6% | -72267.9% |
| Net Margin | -75406.7% | -67975.4% |
| Revenue YoY | -74.1% | -89.9% |
| Net Profit YoY | -2726.9% | 23.7% |
| EPS (diluted) | $-0.22 | $-1.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $255.0K | $240.0K | ||
| Q2 25 | $173.3K | $1.2M | ||
| Q1 25 | $170.7K | $3.0M | ||
| Q4 24 | $212.8K | $12.4M | ||
| Q3 24 | $984.0K | $2.4M | ||
| Q2 24 | $93.0K | $3.1M | ||
| Q1 24 | $124.8K | $56.4M | ||
| Q4 23 | $80.9K | $16.8M |
| Q3 25 | $-192.3M | $-163.1M | ||
| Q2 25 | $-8.9M | $-111.0M | ||
| Q1 25 | $-3.7M | $-121.0M | ||
| Q4 24 | $-4.1M | — | ||
| Q3 24 | $-6.8M | $-213.7M | ||
| Q2 24 | $-5.9M | $-138.4M | ||
| Q1 24 | $-4.8M | $-65.3M | ||
| Q4 23 | $-1.3M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | 99.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 97.9% | ||
| Q2 24 | — | 98.3% | ||
| Q1 24 | — | 99.9% | ||
| Q4 23 | — | 95.2% |
| Q3 25 | -17288.6% | -72267.9% | ||
| Q2 25 | -1553.9% | -9754.3% | ||
| Q1 25 | -970.5% | -4602.5% | ||
| Q4 24 | -5889.5% | — | ||
| Q3 24 | -712.4% | -9718.7% | ||
| Q2 24 | -1857.2% | -5158.7% | ||
| Q1 24 | -1110.9% | -142.0% | ||
| Q4 23 | -1667.7% | — |
| Q3 25 | -75406.7% | -67975.4% | ||
| Q2 25 | -5122.4% | -9139.9% | ||
| Q1 25 | -2195.6% | -3989.6% | ||
| Q4 24 | -1935.5% | — | ||
| Q3 24 | -691.3% | -8979.7% | ||
| Q2 24 | -6313.1% | -4500.1% | ||
| Q1 24 | -3837.7% | -115.8% | ||
| Q4 23 | -1667.7% | — |
| Q3 25 | $-0.22 | $-1.17 | ||
| Q2 25 | $-0.17 | $-0.80 | ||
| Q1 25 | $-0.13 | $-0.88 | ||
| Q4 24 | $-5.62 | — | ||
| Q3 24 | $-3.06 | $-1.56 | ||
| Q2 24 | $-0.58 | $-1.02 | ||
| Q1 24 | $-0.49 | $-0.48 | ||
| Q4 23 | $-0.88 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $109.1M | $497.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.4M | $796.1M |
| Total Assets | $792.6M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $109.1M | $497.8M | ||
| Q2 25 | $2.5M | $598.7M | ||
| Q1 25 | $4.2M | $790.9M | ||
| Q4 24 | $6.2M | $901.0M | ||
| Q3 24 | $2.1M | $909.0M | ||
| Q2 24 | $1.9M | $1.1B | ||
| Q1 24 | $1.9M | $1.1B | ||
| Q4 23 | $2.9M | $1.5B |
| Q3 25 | $779.4M | $796.1M | ||
| Q2 25 | $10.7M | $947.5M | ||
| Q1 25 | $19.6M | $1.0B | ||
| Q4 24 | $23.3M | $1.2B | ||
| Q3 24 | $27.5M | $1.2B | ||
| Q2 24 | $5.4M | $1.4B | ||
| Q1 24 | $11.3M | $1.5B | ||
| Q4 23 | $16.1M | $1.6B |
| Q3 25 | $792.6M | $1.0B | ||
| Q2 25 | $3.3M | $1.2B | ||
| Q1 25 | $5.0M | $1.3B | ||
| Q4 24 | $28.2M | $1.4B | ||
| Q3 24 | $2.6M | $1.5B | ||
| Q2 24 | $2.4M | $1.7B | ||
| Q1 24 | $2.1M | $1.8B | ||
| Q4 23 | $3.1M | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.0M | $-167.6M |
| Free Cash FlowOCF − Capex | — | $-167.9M |
| FCF MarginFCF / Revenue | — | -69952.9% |
| Capex IntensityCapex / Revenue | 0.0% | 132.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-824.0M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-14.0M | $-167.6M | ||
| Q2 25 | $-1.7M | $-120.2M | ||
| Q1 25 | $-1.6M | $-78.1M | ||
| Q4 24 | $-21.6M | $-446.4M | ||
| Q3 24 | $-13.2M | $-171.5M | ||
| Q2 24 | $-1.3M | $-77.8M | ||
| Q1 24 | $-1.0M | $-109.4M | ||
| Q4 23 | $-854.1K | $-778.8M |
| Q3 25 | — | $-167.9M | ||
| Q2 25 | — | $-122.8M | ||
| Q1 25 | — | $-79.7M | ||
| Q4 24 | $-21.6M | $-453.7M | ||
| Q3 24 | $-13.4M | $-174.2M | ||
| Q2 24 | $-1.3M | $-78.5M | ||
| Q1 24 | $-1.1M | $-111.3M | ||
| Q4 23 | — | $-800.4M |
| Q3 25 | — | -69952.9% | ||
| Q2 25 | — | -10111.8% | ||
| Q1 25 | — | -2630.1% | ||
| Q4 24 | -10161.2% | -3666.2% | ||
| Q3 24 | -1360.3% | -7321.3% | ||
| Q2 24 | -1379.4% | -2553.3% | ||
| Q1 24 | -844.7% | -197.4% | ||
| Q4 23 | — | -4767.7% |
| Q3 25 | 0.0% | 132.1% | ||
| Q2 25 | — | 209.1% | ||
| Q1 25 | — | 53.7% | ||
| Q4 24 | 11.3% | 59.0% | ||
| Q3 24 | 18.8% | 116.3% | ||
| Q2 24 | 3.1% | 21.7% | ||
| Q1 24 | 9.5% | 3.3% | ||
| Q4 23 | — | 128.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
